BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36931980)

  • 1. Clinical Implementation of an Artificial Intelligence Algorithm for Magnetic Resonance-Derived Measurement of Total Kidney Volume.
    Potretzke TA; Korfiatis P; Blezek DJ; Edwards ME; Klug JR; Cook CJ; Gregory AV; Harris PC; Chebib FT; Hogan MC; Torres VE; Bolan CW; Sandrasegaran K; Kawashima A; Collins JD; Takahashi N; Hartman RP; Williamson EE; King BF; Callstrom MR; Erickson BJ; Kline TL
    Mayo Clin Proc; 2023 May; 98(5):689-700. PubMed ID: 36931980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Averaging Measurements From Multiple MRI Pulse Sequences on Kidney Volume Reproducibility in Autosomal Dominant Polycystic Kidney Disease.
    Dev H; Zhu C; Sharbatdaran A; Raza SI; Wang SJ; Romano DJ; Goel A; Teichman K; Moghadam MC; Shih G; Blumenfeld JD; Shimonov D; Chevalier JM; Prince MR
    J Magn Reson Imaging; 2023 Oct; 58(4):1153-1160. PubMed ID: 36645114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automatic Measurement of Kidney and Liver Volumes from MR Images of Patients Affected by Autosomal Dominant Polycystic Kidney Disease.
    van Gastel MDA; Edwards ME; Torres VE; Erickson BJ; Gansevoort RT; Kline TL
    J Am Soc Nephrol; 2019 Aug; 30(8):1514-1522. PubMed ID: 31270136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid high-performance semi-automated tool to measure total kidney volume from MRI in autosomal dominant polycystic kidney disease.
    Simms RJ; Doshi T; Metherall P; Ryan D; Wright P; Gruel N; van Gastel MDA; Gansevoort RT; Tindale W; Ong ACM
    Eur Radiol; 2019 Aug; 29(8):4188-4197. PubMed ID: 30666443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of artificial intelligence-based decision supporting system in tolvaptan prescription for autosomal dominant polycystic kidney disease.
    Shin JH; Kim YH; Lee MK; Min HS; Cho H; Kim H; Kim YC; Lee YS; Shin TY
    Investig Clin Urol; 2023 May; 64(3):255-264. PubMed ID: 37341005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Performance of Kidney Volume Measurement for Polycystic Kidney Disease: A Comparative Study of Ellipsoid vs. Manual Segmentation.
    Shi B; Akbari P; Pourafkari M; Iliuta IA; Guiard E; Quist CF; Song X; Hillier D; Khalili K; Pei Y
    Sci Rep; 2019 Jul; 9(1):10996. PubMed ID: 31358787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated measurement of total kidney volume from 3D ultrasound images of patients affected by polycystic kidney disease and comparison to MR measurements.
    Jagtap JM; Gregory AV; Homes HL; Wright DE; Edwards ME; Akkus Z; Erickson BJ; Kline TL
    Abdom Radiol (NY); 2022 Jul; 47(7):2408-2419. PubMed ID: 35476147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automatic total kidney volume measurement on follow-up magnetic resonance images to facilitate monitoring of autosomal dominant polycystic kidney disease progression.
    Kline TL; Korfiatis P; Edwards ME; Warner JD; Irazabal MV; King BF; Torres VE; Erickson BJ
    Nephrol Dial Transplant; 2016 Feb; 31(2):241-8. PubMed ID: 26330562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Artificial Intelligence Generated Automated Algorithm to Measure Total Kidney Volume in ADPKD.
    Taylor J; Thomas R; Metherall P; van Gastel M; Cornec-Le Gall E; Caroli A; Furlano M; Demoulin N; Devuyst O; Winterbottom J; Torra R; Perico N; Le Meur Y; Schoenherr S; Forer L; Gansevoort RT; Simms RJ; Ong ACM
    Kidney Int Rep; 2024 Feb; 9(2):249-256. PubMed ID: 38344736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy and processing time of kidney volume measurement methods in rodents polycystic kidney disease models: superiority of semiautomated kidney segmentation.
    Doss MC; Mullen S; Roye R; Zhou J; Chumley P; Mrug E; Wallace DP; Qian F; Harris PC; Yoder BK; Kim H; Mrug M
    Am J Physiol Renal Physiol; 2023 Apr; 324(4):F423-F430. PubMed ID: 36794756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated Kidney and Liver Segmentation in MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease: A Multicenter Study.
    Woznicki P; Siedek F; van Gastel MDA; Dos Santos DP; Arjune S; Karner LA; Meyer F; Caldeira LL; Persigehl T; Gansevoort RT; Grundmann F; Baessler B; Müller RU
    Kidney360; 2022 Dec; 3(12):2048-2058. PubMed ID: 36591351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Deep Learning Approach for Automated Segmentation of Kidneys and Exophytic Cysts in Individuals with Autosomal Dominant Polycystic Kidney Disease.
    Kim Y; Tao C; Kim H; Oh GY; Ko J; Bae KT
    J Am Soc Nephrol; 2022 Aug; 33(8):1581-1589. PubMed ID: 35768178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep Learning Automation of Kidney, Liver, and Spleen Segmentation for Organ Volume Measurements in Autosomal Dominant Polycystic Kidney Disease.
    Sharbatdaran A; Romano D; Teichman K; Dev H; Raza SI; Goel A; Moghadam MC; Blumenfeld JD; Chevalier JM; Shimonov D; Shih G; Wang Y; Prince MR
    Tomography; 2022 Jul; 8(4):1804-1819. PubMed ID: 35894017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automatic semantic segmentation of kidney cysts in MR images of patients affected by autosomal-dominant polycystic kidney disease.
    Kline TL; Edwards ME; Fetzer J; Gregory AV; Anaam D; Metzger AJ; Erickson BJ
    Abdom Radiol (NY); 2021 Mar; 46(3):1053-1061. PubMed ID: 32940759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated Segmentation of Kidneys from MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease.
    Kim Y; Ge Y; Tao C; Zhu J; Chapman AB; Torres VE; Yu AS; Mrug M; Bennett WM; Flessner MF; Landsittel DP; Bae KT;
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):576-84. PubMed ID: 26797708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T1 vs. T2 weighted magnetic resonance imaging to assess total kidney volume in patients with autosomal dominant polycystic kidney disease.
    van Gastel MDA; Messchendorp AL; Kappert P; Kaatee MA; de Jong M; Renken RJ; Ter Horst GJ; Mahesh SVK; Gansevoort RT;
    Abdom Radiol (NY); 2018 May; 43(5):1215-1222. PubMed ID: 28871393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemorrhagic Cysts and Other MR Biomarkers for Predicting Renal Dysfunction Progression in Autosomal Dominant Polycystic Kidney Disease.
    Riyahi S; Dev H; Blumenfeld JD; Rennert H; Yin X; Attari H; Barash I; Chicos I; Bobb W; Donahue S; Prince MR
    J Magn Reson Imaging; 2021 Feb; 53(2):564-576. PubMed ID: 32969110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Total Kidney Volume Quantification Methods in Autosomal Dominant Polycystic Disease for a Comprehensive Disease Assessment.
    Turco D; Busutti M; Mignani R; Magistroni R; Corsi C
    Am J Nephrol; 2017; 45(5):373-379. PubMed ID: 28315882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy, Reproducibility and User Experience With Standardized Instructions for Measurement of Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease.
    Bevilacqua M; Hague CJ; Romann A; Levin A
    Can Assoc Radiol J; 2023 May; 74(2):343-350. PubMed ID: 36063401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel three-dimensional imaging volumetry in autosomal dominant polycystic kidney disease: comparison with 2D volumetry.
    Shin D; Lee KB; Hyun YY; Lee YR; Hwang YH; Park HC; Ahn C
    Clin Nephrol; 2014 Aug; 82(2):98-106. PubMed ID: 25029513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.